Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: improbable (1), doubtful (8)

Female pelvis radiotherapy - patient information

Description: This factsheet explains what to expect during your radiotherapy treatment to the female pelvis.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Female-pelvis-radiotherapy-1415-PIL.pdf

Leg amputation - patient information

Description: Information about leg amputation surgery, performed as an absolute last resort for poor blood flow to your leg, o
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Leg-amputation-1661-PIL.pdf

Tissue removal and amputation of the toe and the foot - patient information

Description: Information about tissue removal when there is a serious infection in the skin and tissue of the toes and foot
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Tissue-removal-and-amputation-of-the-toe-and-the-foot-1660-PIL.pdf

Carotid endarterectomy - patient information

Description: Information about having a carotid endarterectomy
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Carotid-endarterectomy-1656-PIL.pdf

Endometrial-Dostarlimab

Description: Chemotherapy Protocol GYNACOLOGICAL CANCER Dostarlimab Regimen  Endometrial - Dostarlimab Indication  Dostarlimab is indicated for patients with; - proven histological
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/Dostarlimab.pdf

Avelumab(800mg)

Description: Chemotherapy Protocol BLADDER CANCER AVELUMAB (800mg) Regimen  Bladder Cancer - Avelumab Indication  Avelumab is indicated as monotherapy for the f
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Avelumab800mg.pdf

Remuneration and Appointment Committee ToR May 2022

Description: Remuneration and Appointment Committee Terms of Reference Date Issued: 26 May 2022 Review Date: November 2022 Document Ty
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Remuneration-and-Appointment-Committee-ToR-May-2022.pdf

Total body irradiation (TBI) - patient information

Description: This factsheet explains what to expect at your TBI treatment appointments.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Total-body-irradiation-TBI-1332-PIL.pdf

Preventing blood clots - patient information

Description: Blood normally flows quickly and uninterrupted through our veins. Sometimes, however, clots can form that either reduce the blood flow or
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Preventingbloodclots-patientinformation.pdf

Durvalumab_14day

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (14 day) Regimen • NSCLC - Durvalumab (14 day) Indication • Stage 3 NSCLC after radical chemoradiotherapy •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab-14day.pdf

321 to 330 of 447

Previous … 31 32 33 34 35 … Next